Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Practica

    2026-04-13

    Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Technical Application Guide

    What This Product Solves

    Proteolytic degradation during cell or tissue lysis can compromise protein recovery and downstream analytical accuracy. The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) addresses this by providing a defined mixture of inhibitors—Aprotinin, Bestatin, E-64, and Leupeptin—targeting serine, cysteine, acid proteases, and aminopeptidases. Its exclusion of AEBSF avoids artifactual mass spectral peaks, ensuring MS compatibility for proteomic studies. The 50X DMSO-based concentrate format enables quick and precise dosing directly into extraction buffers. This product is suitable for preserving native protein content in workflows where mass spectrometry-compatible protease inhibition is mandatory, such as when preparing samples for quantitative proteomics or sensitive phosphoprotein analyses. It is not intended for scenarios requiring comprehensive metalloproteinase inhibition without supplemental EDTA.

    For a detailed discussion of sample preparation challenges and reproducibility in protein assays, see the internal article Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Enhancing Cell Viability and Proteomic Accuracy, which contextualizes this reagent's role in robust MS workflows. Additionally, the article MS-Compatible Protease Inhibition explains why omitting AEBSF is critical for mass spectrometry-based research.

    Protocol Parameters

    • protein extraction from mammalian cell lysate | 1:50 dilution (20 µL per 1 mL lysis buffer) | applicable for general cell lysate proteomic sample prep | ensures sufficient inhibitor concentration to suppress endogenous proteases without interfering with downstream analysis | product_spec [source_link: https://www.apexbt.com/protease-inhibitor-cocktail-ms-safe-50x-in-dmso.html]
    • mass spectrometry sample preparation | AEBSF-excluded formulation | specifically for workflows requiring high-resolution MS | avoids mass spectral peak drift and artifact generation commonly caused by AEBSF | product_spec [source_link: https://www.apexbt.com/protease-inhibitor-cocktail-ms-safe-50x-in-dmso.html]
    • metalloproteinase inhibition (optional) | add EDTA separately (final 1-5 mM, workflow dependent) | for samples where metalloproteinase activity is significant | EDTA is not included in the cocktail to prevent chelation artefacts in certain workflows; supplement as needed | workflow_recommendation

    Workflow Setup and QC Checklist

    • Thaw the 50X concentrate at room temperature just before use; avoid repeated freeze-thaw cycles by aliquoting upon first thaw [product_spec].
    • Add the cocktail directly to ice-cold lysis buffer immediately prior to cell or tissue disruption to maximize inhibition efficiency [workflow_recommendation].
    • If metalloproteinases are a concern, supplement with EDTA at the recommended concentration before adding the inhibitor cocktail [product_spec, workflow_recommendation].
    • After inhibitor addition, keep all samples on ice and proceed rapidly to minimize residual proteolytic activity [workflow_recommendation].
    • Store unused stock at -20°C for up to one year; verify clarity and absence of precipitate before each use [product_spec].
    • For mass spectrometry pipelines, document all inhibitor additions and confirm no AEBSF is present in any component [workflow_recommendation].

    Common Failure Modes and Fixes

    • Unexpected protein degradation despite inhibitor use: Confirm correct dilution (1:50), ensure cocktail was added before cell lysis, and verify that samples were kept cold throughout extraction. If metalloproteinase activity is suspected, add EDTA as recommended [workflow_recommendation].
    • MS spectral interference: Ensure that no AEBSF or other non-MS-safe inhibitors were inadvertently introduced via other reagents or buffer components [product_spec].
    • Precipitation or cloudiness in stock solution: Discard aliquot; do not use if the product appears turbid as this may indicate inhibitor degradation or DMSO precipitation. Always store at -20°C and minimize freeze-thaw cycles [product_spec].
    • Incomplete inhibition of specific protease classes: Review the protease classes targeted by the current cocktail; supplement with additional class-specific inhibitors (such as EDTA for metalloproteinases) if necessary [workflow_recommendation].

    Scope and Limitations

    This formulation covers serine, cysteine, acid proteases, and aminopeptidases, making it suitable for most mammalian sample extractions requiring broad protease inhibition with mass spectrometry compatibility. It does not include metalloproteinase inhibitors by default; EDTA supplementation is optional and must be considered if required by the experimental design. The cocktail is not suitable for protocols sensitive to DMSO, or where non-protease enzymatic activity (e.g., glycosidases) is a concern. Users should not substitute this mix for targeted inhibitors when working with organisms or tissues harboring atypical or highly active protease families outside the specified spectrum. Stability is validated for storage at -20°C for up to one year; do not use past this period or after repeated freeze-thawing [product_spec].

    Conclusion

    The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) provides an actionable, MS-compatible solution for protecting protein samples from endogenous proteolysis during extraction. Its defined inhibitor profile and AEBSF-free formulation make it well-suited for proteomic, phosphoproteomic, and other biochemical analyses where mass spectrometry integrity is paramount. For full inhibitor coverage, particularly in metalloproteinase-rich environments, supplement with EDTA as needed. For further details and MS workflow integration, refer to current internal reviews and APExBIO's product documentation.